CHA2DS2-VASc Score Is Directly Associated with the Risk of Pulmonary Embolism in Patients with Atrial Fibrillation Walid Saliba, MD, MPH, Gad Rennert,

Slides:

Advertisements

Similar presentations

Low-Dose Aspirin in Patients with Stable Cardiovascular Disease: A Meta-analysis Jeffrey S. Berger, MD, MS, David L. Brown, MD, Richard C. Becker, MD The.

Advertisements

CHA2DS2-VASC and CHADS2 Scores Predict Adverse Clinical Events in Patients With Pacemakers and Sinus Node Dysfunction Independent of Atrial Fibrillation

Overweight and obesity as risk factors for atrial fibrillation or flutter: The Danish Diet, Cancer, and Health Study Lars Frost, MD, PhD, Lone Juul Hune,

Paul D. Stein, MD, Fadi Matta, MD, Mary J. Hughes, DO

Effects of structured care by a pharmacist-diabetes specialist team in patients with Type 2 diabetic nephropathy Wilson Y.S. Leung, BPharm, PhD, Wing-Yee.

New-onset Atrial Fibrillation Predicts Heart Failure Progression

Grip Strength Predicts Cause-Specific Mortality in Middle-Aged and Elderly Persons Hideo Sasaki, MD, PhD, Fumiyoshi Kasagi, PhD, Michiko Yamada, MD, PhD,

Role of the CHADS2 Score in Acute Coronary Syndromes

Renato D. Lopes, MD, PhD, Li Li, MS, Christopher B

CHADS2 Score Predicts Postoperative Atrial Fibrillation in Patients Undergoing Elective Pulmonary Lobectomy Svetlana Kotova, MD, Mansen Wang, PhD, Katie.

Discharge Heart Rate and Mortality after Acute Myocardial Infarction

Mechanisms, Clinical Significance, and Prevention of Cognitive Impairment in Patients With Atrial Fibrillation Lena Rivard, MD, MSc, Paul Khairy, MD,

Richard V. Milani, MD, Carl J. Lavie, MD, Robert M

Alexander A. Leung, MD, MPH, Finlay A. McAlister, MD, MSc, Samuel R. G

Aruna D. Pradhan, MD, Nader Rifai, PhD, Julie E. Buring, ScD, Paul M

Samy Suissa, PhD, Abbas Kezouh, PhD, Pierre Ernst, MD, MSc

Martin W. Schoen, MD, MPH, Joanne Salas, MPH, Jeffrey F

Trends in Comorbidity, Disability, and Polypharmacy in Heart Failure

Overweight and obesity as risk factors for atrial fibrillation or flutter: The Danish Diet, Cancer, and Health Study Lars Frost, MD, PhD, Lone Juul Hune,

Impact of Hyponatremia Correction on the Risk for 30-Day Readmission and Death in Patients with Congestive Heart Failure Jacques D. Donzé, MD, MSc, Patrick.

Subclinical Thyroid Disease and Mortality in the Elderly: A Retrospective Cohort Study Alon Grossman, MD, MHA, Avraham Weiss, MD, Nira Koren-Morag, PhD,

Trends in Stroke Rates, Risk, and Outcomes in the United States, 1988 to 2008 Margaret C. Fang, MD, MPH, Marcelo Coca Perraillon, MA, Kaushik Ghosh, PhD,

Venous Thromboembolism with Chronic Liver Disease

Prognostic Importance of Low Admission Serum Creatinine Concentration for Mortality in Hospitalized Patients Charat Thongprayoon, MD, Wisit Cheungpasitporn,

SAMe-TT2R2 Score, Time in Therapeutic Range, and Outcomes in Anticoagulated Patients with Atrial Fibrillation Pilar Gallego, MD, PhD, Vanessa Roldán,

Epidemiology of Myelodysplastic Syndromes

Trend in Mortality after Stroke with Atrial Fibrillation

A Randomized, Double-Blind, Placebo-Controlled Trial of Nutritional Supplementation During Acute Illness Salah Gariballa, MD, Sarah Forster, MSc, Stephen.

The Impact of Race on the Prognosis of Preclinical Diastolic Dysfunction: A Large Multiracial Urban Population Study Jian Shan, MD, Lili Zhang, MD, MSc,

Obstructive Sleep Apnea as a Risk Factor for Type 2 Diabetes

Pulmonary Embolism with Right Ventricular Dysfunction: Who Should Receive Thrombolytic Agents? Hem Desai, MD, MPH, Bhupinder Natt, MD, Christian Bime,

Osteoporotic Fractures and Heart Failure in the Community

Gregory Y.H. Lip, MD, Jonathan L. Halperin, MD, Hung-Fat Tse, MD, PhD

Rate-control versus Rhythm-control Strategies and Outcomes in Septuagenarians with Atrial Fibrillation Nasir Shariff, MD, Ravi V. Desai, MD, Kanan Patel,

CHADS2 Score, Statin Therapy, and Risks of Atrial Fibrillation

TIA for the Internist The American Journal of Medicine

History of Thyroid Disorders in Relation to Clinical Outcomes in Atrial Fibrillation Helene Bruere, MD, Laurent Fauchier, MD, PhD, Anne Bernard Brunet,

Gout in African Americans

Matthew W. Parker, MD, Murray A. Mittleman, MD, DrPH, Carol A

Are Atrial Fibrillation Patients Receiving Warfarin in Accordance with Stroke Risk? Peter J. Zimetbaum, MD, Amit Thosani, MD, Hsing-Ting Yu, MPH, Yan.

Evaluation of the HAS-BLED, ATRIA, and ORBIT Bleeding Risk Scores in Patients with Atrial Fibrillation Taking Warfarin Keitaro Senoo, MD, Marco Proietti,

Interaction of Physical Activity and Body Mass Index on Mortality in Coronary Heart Disease: Data from the Nord-Trøndelag Health Study Trine Moholdt,

When Guidelines Cause Hypertension

Left atrial appendage exclusion: An alternative to anticoagulation in nonvalvular atrial fibrillation Kareem Bedeir, MBChB, MS, David R. Holmes, MD,

Isla M. Ogilvie, PhD, Nick Newton, PhD, Sharon A

Repeated Hemoglobin A1C Ordering in the VA Health System

Molly E. Waring, PhD, Jane S

Persistent Insomnia is Associated with Mortality Risk

Optimizing Atrial Fibrillation Management

Volume 16, Issue 1, Pages 3-9 (January 2019)

Scope of Problem of Pulmonary Arterial Hypertension

The Reply The American Journal of Medicine

The Relationship Between Serum 25(OH)D and Parathyroid Hormone Levels

Usefulness of CHADS2 and CHA2DS2-VASc Scores in the Prediction of New-Onset Atrial Fibrillation: A Population-Based Study Walid Saliba, MD, MPH, Naomi.

Elevated High-Density Lipoprotein Cholesterol Is Associated with Hyponatremia in Hypertensive Patients Ariel Israel, MD, PhD, Ehud Grossman, MD The.

Shannon M. Dunlay, MD, MS, Quinn R. Pack, MD, Randal J

Prevalence and Risk Factors for Erectile Dysfunction in the US

Age Differences in Treatment and Control of Hypertension in US Physician Offices, : A Serial Cross-sectional Study Anna Gu, MD, PhD, Yu Yue,

Stroke and Bleeding Risk Co-distribution in Real-world Patients with Atrial Fibrillation: The Euro Heart Survey Maura Marcucci, MD, Gregory Y.H. Lip,

John-Michael Gamble, BScPharm, MSc, Dean T. Eurich, PhD, Thomas J

Evaluation of Severe Infection and Survival After Splenectomy

Sushrut S. Waikar, MD, MPH, Gary C. Curhan, MD, ScD, Steven M

Higher Cardiovascular Disease Prevalence and Mortality among Younger Blacks Compared to Whites Stacey Jolly, MD, MS, Eric Vittinghoff, PhD, Arpita Chattopadhyay,

The Association Between Barium Examination and Subsequent Appendicitis: A Nationwide Population-Based Study Hao-Ming Li, MD, Lee-Ren Yeh, MD, Ying-Kai.

Figure 8. Stroke prevention strategy in patients with AF

Has mortality from acute renal failure decreased

Longer Lengths of Stay and Higher Risk of Mortality among Inpatients of Physicians with More Years in Practice William N. Southern, MD, MS, Eran Y. Bellin,

Effects of structured care by a pharmacist-diabetes specialist team in patients with Type 2 diabetic nephropathy Wilson Y.S. Leung, BPharm, PhD, Wing-Yee.

Secular trends in cardiovascular disease mortality, incidence, and case fatality rates in adults in the United States Ahmet Ergin, MD, PhD, MPH, Paul.

Dean T. Eurich, PhD, Cheryl A. Sadowski, PharmD, Scot H

Presentation transcript:

CHA2DS2-VASc Score Is Directly Associated with the Risk of Pulmonary Embolism in Patients with Atrial Fibrillation Walid Saliba, MD, MPH, Gad Rennert, MD, PhD The American Journal of Medicine Volume 127, Issue 1, Pages 45-52 (January 2014) DOI: 10.1016/j.amjmed.2013.10.004 Copyright © 2014 Elsevier Inc. Terms and Conditions

Figure 1 Incidence rate of pulmonary embolism (A) and all-cause mortality (B) according to CHA2DS2-VASc score; CHS cohort, Israel. CHA2DS2-VASc = Congestive heart failure, Hypertension, Age ≥75 [doubled], Diabetes, Stroke [doubled] – Vascular disease, Age 65-74, and Sex category [female]. The American Journal of Medicine 2014 127, 45-52DOI: (10.1016/j.amjmed.2013.10.004) Copyright © 2014 Elsevier Inc. Terms and Conditions

Figure 2 Kaplan-Meier curves according to CHA2DS2-VASc score categories:* pulmonary embolism (A) and all-cause mortality (B); CHS cohort, Israel. CHA2DS2-VASc = Congestive heart failure, Hypertension, Age ≥75 [doubled], Diabetes, Stroke [doubled] – Vascular disease, Age 65-74, and Sex category [female]. The American Journal of Medicine 2014 127, 45-52DOI: (10.1016/j.amjmed.2013.10.004) Copyright © 2014 Elsevier Inc. Terms and Conditions